101
Participants
Start Date
March 30, 2015
Primary Completion Date
June 2, 2017
Study Completion Date
February 21, 2018
Vedolizumab
Vedolizumab intravenous injection
La Jolla
Hamden
Gainesville
Inverness
Maitland
Miami
Winter Park
Macon
Suwanee
Topeka
Baton Rouge
Columbia
Boston
Ann Arbor
St Louis
Manhasset
Poughkeepsie
Winston-Salem
Cleveland
Tulsa
Portland
Germantown
Bonheiden
Brussels
Herentals
Kortrijk
Leuven
Roeselare
Vancouver
Victoria
Halifax
London
Vaughan
Hradec Králové
Kladno
Pardubice
Prague
Nice
Pessac
Reims
Lille
Saint-Étienne-de-Montluc
Lille
Nantes
Nice
Pessac
Reims
Saint-Etienne
Toulouse
Békéscsaba
Budapest
Debrecen
Gyöngyös
Gyula
Jászberény
Kistarcsa
Miskolc
Mosonmagyaróvár
Pécs
Szeged
Szekszárd
Székesfehérvár
Vác
San Giovanni Rotondo
Rozzano
San Donato Milanese
Bologna
Florence
Napoli
Padua
Roma
Rozzano
San Donato Milanese
San Giovanni Rotondo
Bialystok
Elblag
Poznan
Warsaw
Wroclaw
Lead Sponsor
Takeda
INDUSTRY